Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 31;13(6):930.
doi: 10.3390/jpm13060930.

The Challenges and Therapeutic Prospects in Eye Disease

Chieh-Chih Tsai  1   2
Affiliations
Editorial

The Challenges and Therapeutic Prospects in Eye Disease

Chieh-Chih Tsai. J Pers Med. .

Abstract

A number of key insights into eye disease have been revealed in the past decade, which has resulted in the development of novel, effective, targeted therapies such as teprotumumab for the treatment of thyroid eye disease (also known as Graves' orbitopathy) [...].

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Douglas R.S., Kahaly G.J., Ugradar S., Elflein H., Ponto K.A., Fowler B.T., Dailey R., Harris G.J., Schiffman J., Tang R., et al. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study. Ophthalmology. 2022;129:438–449. doi: 10.1016/j.ophtha.2021.10.017. - DOI - PubMed
    1. Pham B., Thomas S.M., Lillie E., Lee T., Hamid J., Richter T., Janoudi G., Agarwal A., Sharpe J.P., Scott A., et al. Anti-vascular endothelial growth factor treatment for retinal conditions: A systematic review and meta-analysis. BMJ Open. 2019;28:e022031. doi: 10.1136/bmjopen-2018-022031. - DOI - PMC - PubMed
    1. Yu W.K., Tsai C.C., Kao S.C., Liu C.J.L. Immunoglobulin G4-related ophthalmic disease. Taiwan J. Ophthalmol. 2018;8:9–14. doi: 10.4103/tjo.tjo_12_17. - DOI - PMC - PubMed
    1. Yu W.K., Kao S.C., Yang C.F., Lee F.L., Tsai C.C. Ocular adnexal IgG4-related disease: Clinical features, outcome, and factors associated with response to systemic steroids. Jpn. J. Ophthalmol. 2015;59:8–13. doi: 10.1007/s10384-014-0353-1. - DOI - PubMed
    1. Chou W.Y., Tsai C.Y., Tsai C.C. Long-Term Follow-Up in IgG4-Related Ophthalmic Disease: Serum IgG4 Levels and Their Clinical Relevance. J. Pers. Med. 2022;12:1963. doi: 10.3390/jpm12121963. - DOI - PMC - PubMed

Publication types

LinkOut - more resources